In adult male Sprague‐Dawley rats with lithium/pilocarpine‐induced ESE, Flupirtine did not reduce mean SE duration compared with saline control treatment. In hypoxia-exposed male Wistar rats receiving Flupirtine maleate by gavage, the isolated-lung P/Q slope was 0.475 ± 0.022 mmHg·min/ml, with a reported difference versus hypoxia and hypoxia with vehicle. [2,3]
Flupirtine treatment alone did not effectively treat lithium/pilocarpine‐induced ESE
Animal study · Adult male Sprague‐Dawley rats; lithium/pilocarpine‐induced ESE [2]
Adult male Sprague‐Dawley rats with lithium/pilocarpine‐induced ESE received Flupirtine at 50 mg/kg i.p. Compared with saline control treatment, Flupirtine did not reduce mean SE duration, reported as 7.86 ± 1.5 h.
Conditions shared by the study groups
- Route
- i.p.
- Treatment course
- 10 min after the onset of continuous electrographic seizure activity
- Flupirtine 50 mg/kg
- Model: Adult male Sprague‐Dawley rats; lithium/pilocarpine‐induced ESE
- Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Flupirtine
The paper names Flupirtine without stating the salt or form; not verified as the maleate form supplied as A10251. No dose conversion or lot validation.
Methods (S2, S3); Methods > Lithium/pilocarpine method (S6, S7); Methods > DFP (S27); Results (S35, S36, S37, S38); Figure 2 legend (S72, S75); Figure 3 legend (S85)
mean SE duration: mean SE duration; comparator: saline control treatment — Results (S38)
Flupirtine 50 mg/kg · Results (S35, S36, S38)
Pulmonary Pressure–Flow Relationship in Hypoxia-Exposed Rats
Animal study · male Wistar rats [3]
Male Wistar rats exposed to hypoxia received Flupirtine maleate at 15 mg/kg by gavage. The hypoxia-plus-flupirtine group had an isolated-lung P/Q slope of 0.475 ± 0.022 mmHg·min/ml, with a reported difference versus hypoxia and hypoxia with vehicle.
Conditions shared by the study groups
- Route
- by gavage
- Treatment course
- Groups of rats were exposed to an hypoxic environment by maintaining them in an isobaric hypoxic chamber (FiO2 0.1) for 5 days (14). One group of rats exposed to hypoxia was administered flupirtine 15 mg/kg twice a day by gavage (n = 6) throughout the exposure period.
- Vehicle
- dimethyl sulfoxide (DMSO)
- Flupirtine maleate 15 mg/kg
- Model: male Wistar rats
Methods and source locations
Compound reported in the paper: Flupirtine maleate; Compound label in the paper: Flupirtine
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
METHODS (S1); METHODS > Untitled > In vivo treatment. (S40, S42, S43); RESULTS > Untitled > Flupirtine inhibits hypoxic pulmonary hypertension. (S124); Table 2. legend (S158); Table 2. (T2.h1, T2.r3, T2.r4)
P/Q relationship and vascular reactivity measured in isolated lungs.: P/Q relationship and vascular reactivity measured in isolated lungs.; comparator: Hypoxia + vehicle — RESULTS > Untitled > Flupirtine inhibits hypoxic pulmonary hypertension. (S124); Table 2. legend (S158); Table 2. (T2.h1, T2.r3)
Flupirtine maleate 15 mg/kg · METHODS > Untitled > In vivo treatment. (S40, S42); RESULTS > Untitled > Flupirtine inhibits hypoxic pulmonary hypertension. (S124); Table 2. legend (S158); Table 2. (T2.h1, T2.r3)